Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 Cases

Treatment options for patients with advanced sarcoma remain limited. Promising responses to checkpoint inhibition have been observed, but responses to single-agent PD-1 inhibition are rare. We report on two patients with multiply recurrent myxofibrosarcoma treated with the combination of regionally...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartlett, Edmund K., D’Angelo, Sandra P., Kelly, Ciara M., Siegelbaum, Robert H., Fisher, Charles, Antonescu, Cristina R., Ariyan, Charlotte E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554327/
https://www.ncbi.nlm.nih.gov/pubmed/34722269
http://dx.doi.org/10.3389/fonc.2021.725484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554327/
https://www.ncbi.nlm.nih.gov/pubmed/34722269
http://dx.doi.org/10.3389/fonc.2021.725484

Ejemplares similares